News Releases

Nationwide, the rollout for the COVID-19 vaccine has been inequitable, with white individuals being vaccinated at higher rates compared to Black individuals. In Philadelphia, only 21 percent of the vaccine had gone to Black residents by March 2021, even though this group makes up 42 percent of the city’s population.

A new study published today in Health Affairs reveals that Medicaid expansion is associated with substantial improvements in access to medications for OUD for individuals referred to substance use treatment by criminal justice agencies.

While the emergency department (ED) functions as an integral part of the United States healthcare safety net by handling all medical complaints regardless of insurance status, ED visits are expensive, and many are for lower-acuity conditions that may be amenable to care in other settings.

A team led by scientists at the Perelman School of Medicine at the University of Pennsylvania has illuminated the functions of mysterious structures in cells called “nuclear speckles,” showing that they can work in partnership with a key protein to enhance the activities of specific sets of genes.

A team led by scientists in the Perelman School of Medicine at the University of Pennsylvania has identified nine potential new COVID-19 treatments, including three that are already approved by the Food and Drug Administration (FDA) for treating other diseases.

The Penn Nerve Center, led by Zarina Ali, MD and L. Scott Levin, MD, combining experts in neurosurgery, orthopaedics, plastic surgery, physical medicine and rehab, neurology, and radiology, the Center is the first of its kind in the region.

A Penn Medicine patient with a genetic form of childhood blindness gained vision, which lasted more than a year, after receiving a single injection of an experimental RNA therapy into the eye. The clinical trial was conducted by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania.

CORONA is the world’s largest database of COVID-19 treatments, covering 400+ treatments that have been reported to be administered to 340,000+ patients, helping researchers to identify and prioritize promising treatments for well-designed clinical trials and to inform patient care.